Your session is about to expire
← Back to Search
Gain-framed messaging plus NRT for Smoking Cessation
Study Summary
This trial is testing a new way to help lung cancer patients quit smoking, by framed messaging and nicotine replacement therapy. If successful, this study could help many people quit smoking.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have serious heart rhythm problems.I have unstable chest pain.I am currently in a program to help me stop smoking.I am 50 years old or older.I have smoked at least 20 packs of cigarettes a year.I am willing to be assigned to a treatment group by chance.My heart's function is stable.You recently had a heart attack within the last two weeks.You have smoked in the last 30 days.You have a history of severe mental health issues or dementia that may affect your ability to participate in the study.
- Group 1: No NRT - Unframed Messaging
- Group 2: NRT plus Gain-framed Messaging
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the Food and Drug Administration recognize gain-framed messaging combined with nicotine replacement therapy as a legitimate treatment?
"The safety profile of Gain-framed messaging plus NRT was judged to be a 2 on the 1-3 scale, as this is a Phase 2 trial. This means that some data has been collected in regards to its safety, but nothing yet exists with regards to efficacy."
Is there availability for participants in this trial?
"As indicated on clinicaltrials.gov, the trial is currently accepting patients and was initially posted in July 2017 with its most recent update taking place November 2022."
What has been the outcome of previous experiments that incorporated both incentive-based messaging and nicotine replacement therapy?
"Initially examined in 2006 at the University of Hong Kong, gain-framed messaging plus NRT has been tested 396 times since. At present, 71 trials are running with a considerable number based out of Charleston, South carolina."
How many participants are being treated through this trial?
"Affirmative. The clinicaltrials.gov platform indicates that this research trial is presently recruiting patients; the initial posting was on July 1st 2017 and it has been recently modified as of November 11th 2022. 367 participants are needed from two different medical centres to complete the study's requirements."
Share this study with friends
Copy Link
Messenger